Novartis Corporation Asked to End Challenge to Indian Patent Law

Pharma Times -- Novartis has been urged to drop its "persistent legal actions" in India regarding patent coverage for its anticancer drug Glivec and a challenge to the country's patent laws over fears the latter could hinder access to medicines.